European Union´s Horizon 2020 – Lipum2019-01-31T10:20:32+00:00

OFFICAL PROJECT SITE 

Novel Target for Treatment of Chronic Inflammatory Diseases — Notid

2908, 2018

Lipum receives 2.2 M€ grant from Horizon 2020

August 29th, 2018|

Lipum's unique approach for treatment of chronic inflammatory diseases receives 2.2 M€ support from EU Horizon 2020, the EU framework program for research and development, will grant 2.2 million euros to Lipum’s ongoing development of a biological pharmaceutical for treatment of chronic inflammatory diseases. Lipum has identified the novel target [...]

Program:
European Commission Horizon 2020
SME Instrument phase 1 No 744248
SME Instrument phase 2 No 829741

Project title:
Novel Target for Treatment of Chronic Inflammatory Diseases

Project budget:
3.2 M€

Funding from the EU:
2.2 M€

Start:
2018-11-01

End:
2020-07-31